| Code | 08484 | ||||||||||
| MA number | 87/0281/11-S | ||||||||||
| Product Form: | plv ifo 4x500 mg (liek.inj.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Pharmaselect International Beteiligungs GmbH, Austria | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | brown glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 17.06.2011 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Cyrdanax 20 mg_ml_12.2018.doc
|
| PIL: |
PIL_Cyrdanax 20 mg_ml_12.2018.doc
|
| Safety feature | Yes |
| Data update: | 24.02.2020 |
